At Merck, our goal is to translate breakthrough science into innovative oncology medicines. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry.
This content is intended only for health care professionals of the United States, its territories, and Puerto Rico. Copyright © 2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.